SAA has also been reported to attenuate injury of kidney disease, which can be attributed to anti-inflammatory and anti-xidative activities by inhibiting the NF-κB and p38 MAPK signaling pathways and activating the Akt/GSK-3β/Nrf2 signaling pathway [37, 48]. Here, NFKB1 is linked to kidney disorder.